Menu
GWAS Study

A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.

Martin JE, Assassi S, Diaz-Gallo LM et al.

23740937 PubMed ID
GWAS Study Type
21109 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MJ
Martin JE
AS
Assassi S
DL
Diaz-Gallo LM
BJ
Broen JC
SC
Simeon CP
CI
Castellvi I
VE
Vicente-Rabaneda E
FV
Fonollosa V
ON
Ortego-Centeno N
GM
González-Gay MA
EG
Espinosa G
CP
Carreira P
CM
Camps M
SJ
Sabio JM
DS
D'alfonso S
VM
Vonk MC
VA
Voskuyl AE
SA
Schuerwegh AJ
KA
Kreuter A
WT
Witte T
RG
Riemekasten G
HN
Hunzelmann N
AP
Airo P
BL
Beretta L
SR
Scorza R
LC
Lunardi C
VL
Van Laar J
CM
Chee MM
WJ
Worthington J
HA
Herrick A
DC
Denton C
FC
Fonseca C
TF
Tan FK
AF
Arnett F
ZX
Zhou X
RJ
Reveille JD
GO
Gorlova O
KB
Koeleman BP
RT
Radstake TR
VT
Vyse T
MM
Mayes MD
AM
Alarcón-Riquelme ME
MJ
Martin J
Chapter II

Abstract

Summary of the research findings

Systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are two archetypal systemic autoimmune diseases which have been shown to share multiple genetic susceptibility loci. In order to gain insight into the genetic basis of these diseases, we performed a pan-meta-analysis of two genome-wide association studies (GWASs) together with a replication stage including additional SSc and SLE cohorts. This increased the sample size to a total of 21,109 (6835 cases and 14,274 controls). We selected for replication 19 SNPs from the GWAS data. We were able to validate KIAA0319L (P = 3.31 × 10(-11), OR = 1.49) as novel susceptibility loci for SSc and SLE. Furthermore, we also determined that the previously described SLE susceptibility loci PXK (P = 3.27 × 10(-11), OR = 1.20) and JAZF1 (P = 1.11 × 10(-8), OR = 1.13) are shared with SSc. Supporting these new discoveries, we observed that KIAA0319L was overexpressed in peripheral blood cells of SSc and SLE patients compared with healthy controls. With these, we add three (KIAA0319L, PXK and JAZF1) and one (KIAA0319L) new susceptibility loci for SSc and SLE, respectively, increasing significantly the knowledge of the genetic basis of autoimmunity.

up to 2,761 European ancestry systemic sclerosis cases, 769 European ancestry systemic lupus erythematosus cases, 7,381 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

21109
Total Participants
GWAS
Study Type
Yes
Replicated
up to 1,578 European ancestry systemic sclerosis cases, 1,727 European ancestry systemic lupus erythematosus cases, 6,893 European ancestry controls
Replication Participants
European
Ancestry
U.S., Netherlands, Germany, Spain, Italy, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.